Gustavo Pinheiro Santana

Gustavo Pinheiro Santana

Auto-generated profile, based on publicly available information

Gustavo Pinheiro Santana

Hospital Ana Nery

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2024 in Structural Heart
Verified
Journal Article
Open access
GSGustavo P. Santana
Gustavo P. Santana
RMRodrigo M. Vieira de Melo
Rodrigo M. Vieira de Melo
TVTainá T. Viana
Tainá T. Viana
DSDaniela N. Velame da Silva
Daniela N. Velame da Silva
CFClara S. Figueiredo
Clara S. Figueiredo
LPLuiz C.S. Passos
Luiz C.S. Passos
Background: Tricuspid valve repair during mitral valve replacement surgery remains a controversial topic. The riskbenefit ratio in some populations remains uncertain, especially in rheumatic heart disease patients. Therefore, we aimed to evaluate the impact of concomitant tricuspid repair on surgical mortality in patients undergoing cardiac surgery due to rheumatic mitral valve disease who have moderate to severe functional tricuspid regurgitation. Methods: This is a prospective cohort study from January 1, 2017, to December 30, 2022. All patients over 18 years of age who underwent cardiac surgery to correct rheumatic mitral valve disease with concomitant moderate to severe tricuspid regurgitation were included. The primary outcome was a surgical death. In an exploratory analysis, clinical and echocardiographic data were obtained 2 years after the procedure. Results: Of the 144 patients included, 83 (57.6%) underwent tricuspid valve repair. The mean age was 46.2 (+/- 12.3) years with 107 (74.3%) female individuals, the median left ventricular ejection fraction was 61.0% (5567), and systolic pulmonary artery pressure (sPAP) was 55.0 mmHg (46-74), with 45 (31.3%) individuals with right ventricular dysfunction. The total in-hospital mortality was 15 (10.4%) individuals, and there was no difference between the groups submitted or not to tricuspid repair: 10 (12.0%) vs. 5 (7.5%); p = 0.46, respectively. There was an association with one variable independently: the sPAP value, relative risk 1.04 (1.01-1.07), p = 0.01. The estimated cut-off value of sPAP that indicates higher early mortality through the receiver operating characteristic curve (area 0.70, p = 0.012) was 73.5 mmHg. Conclusions: Performing tricuspid repair in individuals who were undergoing cardiac surgery to correct rheumatic mitral valve disease was not associated with increased surgical mortality. Our results suggest the safety of tricuspid repair even in this high-risk population, reinforcing the recommendations in current guidelines.

29 November 2022
Verified
Preprint
Open access
PDF file
ECEdmundo J. N. Câmara
Edmundo J. N. Câmara
FVFlávia R. Valladares
Flávia R. Valladares
KKKin Key
Kin Key
PFPaloma Fonseca
Paloma Fonseca
JKJun Kawaoka
Jun Kawaoka
TMThaise Gordiano Machado
Thaise Gordiano Machado
Background: Left atrial (LA) volume indexing for body surface area (BSA) may underestimate LA size in obese and overweight people. Since LA volume is a risk marker for some cardiovascular events, it is suggested that indexing for height would be an alternative more apropriated method. The aims of this study were to find normal and the best cutoff values for LA volume indexed for height in our population. Methods: Echocardiograms from 2018 to 2021 were reviewed and patients without known cardiac disease and completely normal echocardiograms that had the left atrial volume (LAvol) measured by biplane Simpson’s method were included. LAvol was indexed by BSA (ml/m²), by height (LAvol/m), by height raised to exponent 2.7 (ml/ m2.7) and by height squared (ml/h²). Results: A total of 545 patients, 50.5 ± 13.4 y., 335 females (61,5%) were analyzed. There were 145 normal weight (26.6%), 215 overweight (39.4%), 154 obese (28.3%) and 31 low weight (5.7%) patients. To estabilish normal values we included only the normal weight group and considered normal values from 2SD below to 2SD above the mean. Mean and normal values were: LAvol/h 26.0 ±4.5, 17 – 30 ml/m, LAvol/ht² 16 ± 2.8, 10.4 - 21.6 ml/ ht² and LAvol/ht2.7 11.4 ± 2.2, 7.0 - 15.8 ml/m2.7. The normal LAvol/ht2.7 differed between male and female (11.4 ± 2.4 and 12.8 ± 2.6, p = 0.000). LA diameter, LAvol, LAvol/h, LAvol/h² and LAvol/ht2.7 increased progressively from low-weight, normal weight, overweight and obese patients (p= 0.0000), but not LAvol/BSA. When indexing LAvol for height, for height² and for height2.7 20.8%, 22.7% and 21.4% of the obese patients, respectively, were reclassified as enlarged LA, and 7.4%, 8.8% and 8.4% of the overweight patients as well. Using ROC curve analysis, LAvol/h² had the highest AUC ant the best predictive value to identify LA enlargement and LAvol/BSA the worst one. Conclusions: normal values for LAvol indexed for height by three different methods are described in normal individuals. We reinforce that LAvol indexation for BSA underestimates LA size in obese and overweight patients and in these groups, specially, indexing for height² is probably the best method to evaluate LAvol.

30 September 2024 in ABC Heart Failure & Cardiomyopathy
Verified
Journal Article
Open access
PDF file
WCWilliam Carvalho
William Carvalho
LPLuíz Carlos Santana Passos
Luíz Carlos Santana Passos
TVTainá Teixeira Viana
Tainá Teixeira Viana
GSGustavo Pinheiro Santana
Gustavo Pinheiro Santana
JPJackson Pedro Barros Pereira
Jackson Pedro Barros Pereira
CCCaio Rebouças Fonseca Cafezeiro
Caio Rebouças Fonseca Cafezeiro
Fundamento: A terapia de ressincronização cardíaca (TRC) traz benefícios para pacientes com insuficiência cardíaca (IC) que apresentam bloqueio de ramo esquerdo. No entanto, os benefícios da TRC em pacientes com estimulação cardíaca prévia ainda são incertos. Objetivo: Comparar a mortalidade de curto prazo entre o upgrade e a implantação de TRC de novo. Métodos: Estudo de coorte prospectiva que incluiu pacientes com IC indicados para TRC com fração de ejeção do ventrículo esquerdo (FEVE) inferior a 35%. A sobrevida global foi avaliada pelo método de Kaplan-Meier, e a análise multivariada foi realizada utilizando o modelo de regressão de Cox. Resultados: Foram avaliados 412 pacientes com um acompanhamento médio de 59 ± 8 meses. Destes, 104 pacientes estiveram no grupo upgrade enquanto 308 pacientes foram incluídos grupo de novo. A doença de Chagas foi a causa mais prevalente de IC, com 148 casos (36%). Enquanto o grupo de novo cursou com aumento da FEVE (de 25% ± 6,7% para 28% ± 16,3%, p = 0,005), os pacientes que realizaram upgrade não apresentaram diferença estatística na FEVE aos 6 meses (de 27,5% ± 6,9% para 27,5% ± 15,5%, p = 0,6). A mortalidade global em 1 ano foi de 122 casos (29,6%). Em análise multivariada, apenas FEVE e upgrade de TRC permaneceram independentemente associadas ao desfecho (hazard ratio: 0,93, intervalo de confiança: 0,90 a 0,97, p = 0,001; hazard ratio: 2,90, intervalo de confiança: 1,21 a 7,10, p = 0,002, respectivamente). Conclusão: Nesta população de IC, o grupo upgrade foi associado à maior mortalidade em 1 ano quando comparado com o grupo de novo.

24 February 2023
Verified
Preprint
Open access
PDF file
TVTaina Teixeira Viana
Taina Teixeira Viana
GSGustavo Pinheiro Santana
Gustavo Pinheiro Santana
WCWilliam Carvalho
William Carvalho
LPLuiz Carlos Santana Passos
Luiz Carlos Santana Passos
AGAline Grimaldi
Aline Grimaldi
RMRodrigo Morel Vieira de Melo
Rodrigo Morel Vieira de Melo
Title: Upgrade is independently associated with short-term mortality after cardiac resynchronization therapy.

1 October 2024 in ABC Heart Failure & Cardiomyopathy
Verified
Journal Article
Open access
PDF file
WCWilliam Carvalho
William Carvalho
LPLuíz Carlos Santana Passos
Luíz Carlos Santana Passos
TVTainá Teixeira Viana
Tainá Teixeira Viana
GSGustavo Pinheiro Santana
Gustavo Pinheiro Santana
JPJackson Pedro Barros Pereira
Jackson Pedro Barros Pereira
CCCaio Rebouças Fonseca Cafezeiro
Caio Rebouças Fonseca Cafezeiro
Background: Cardiac resynchronization therapy (CRT) is beneficial for patients with heart failure (HF) who have left bundle branch block. However, the benefits of CRT in patients with prior cardiac stimulation remain uncertain. Objective: Compare short-term mortality between upgrade and de novo CRT implantation. Methods: This prospective cohort study included patients with HF indicated for CRT with left ventricular ejection fraction (LVEF) below 35%. Overall survival was assessed using the Kaplan–Meier method, and multivariate analysis was performed using a Cox [...] Abstract Background: Cardiac resynchronization therapy (CRT) is beneficial for patients with heart failure (HF) who have left bundle branch block. However, the benefits of CRT in patients with prior cardiac stimulation remain uncertain. Objective: Compare short-term mortality between upgrade and de novo CRT implantation. Methods: This prospective cohort study included patients with HF indicated for CRT with left ventricular ejection fraction (LVEF) below 35%. Overall survival was assessed using the Kaplan–Meier method, and multivariate analysis was performed using a Cox

1 February 2023
Verified
Preprint
Open access
PDF file
GSGustavo Pinheiro Santana
Gustavo Pinheiro Santana
RMRodrigo M Vieira De Melo
Rodrigo M Vieira De Melo
TVTainá T Viana
Tainá T Viana
LDLuanna M Damasceno
Luanna M Damasceno
PSPedro F Soares
Pedro F Soares
LPLuiz Cs Passos
Luiz Cs Passos
Objective: In a population of patients undergoing cardiac surgery for rheumatic mitral valve disease, evaluate the impact of preoperative PH on early surgical mortality. Methods: This is a prospective cohort carried out from January 1, 2017 to December 30, 2020. All patients over 18 years of age who underwent cardiac surgery to correct rheumatic mitral valve disease with functional tricuspid regurgitation in an echocardiogram performed up to 6 months before surgery were included. Systolic pulmonary artery pressure (sPAP) value was also defined by preoperative echocardiogram evaluation. The primary outcome was surgical mortality. Results: 144 patients were included. The mean age was 46.2 (±12.3) years with 107 (74.3%) female individuals, the median left ventricular ejection fraction was 61.0% (55 - 67) and sPAP was 55.0 mmHg (46 - 74), with 45 (31.3%) individuals with right ventricular dysfunction. The predominant valve disease was mitral stenosis (74.3%). The prevalence of severe tricuspid regurgitation was 47.2%. The total in-hospital mortality was 15 (10.4%) individuals. sPAP was independently associated with early surgical death RR 1.04 (1.01 – 1.07), p = 0.003. To determine a sPAP cut-off that indicates higher mortality and help decision making in clinical practice, we performed an analysis through the ROC curve (area 0.70, p=0.012). The estimated value of 73.5mmHg has the highest accuracy in our model for predicting early mortality. Conclusion: In patients with rheumatic heart disease who will undergo mitral valve surgery, pulmonary hypertension is associated with higher early mortality. Values above 73.5 mmHg predict higher risk and, in this part of the population, additional measures to control intraoperative and immediate postoperative pulmonary hypertension should be considered.